Literature DB >> 622221

Sulpiride and extrapyramidal syndromes in chronic heroin addiction.

D De Maio, M A Caponeri, V Cicchetti, C Mellado, G Scieghi.   

Abstract

During the treatment of 53 young heroin addicts with intramuscular sulpiride for the prevention of withdrawal symptoms, the emergence of extrapyramidal manifestations involving the head, neck and upper trunk in about 40 percent of the patients has been observed. These symptoms occurred with sulpiride dosages in the 'antineurotic' range (not more than 400 mg daily), which practically never produce such symptoms in patients receiving the drug for other clinical indications. The symptoms appeared soon after the first few injections of sulpiride, and yielded readily to a single or repeated intravenous diazepam administration (10 mg). The possible mechanism involved in the production of extrapyramidal manifestations from sulpiride, and a tentative explanation of why such symptoms are produced by doses of this drug lower than those needed to produce the same effects in nonaddicts, are discussed.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 622221     DOI: 10.1159/000117618

Source DB:  PubMed          Journal:  Neuropsychobiology        ISSN: 0302-282X            Impact factor:   2.328


  2 in total

1.  Neuroleptic-induced acute dyskinesias in squirrel monkeys: correlation with propensity to cause extrapyramidal side effects.

Authors:  J Liebman; R Neale
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

2.  Extrapyramidal Side Effects in a Patient with Alcohol Withdrawal Symptoms: A Reflection of Quality of the Mental Health Care System.

Authors:  Mark Mohan Kaggwa; Rahel Nkola; Sarah Maria Najjuka; Felix Bongomin; Scholastic Ashaba; Mohammed A Mamun
Journal:  Risk Manag Healthc Policy       Date:  2021-07-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.